FDA authorizes two COVID boosters targeted at Omicron subvariants
The U.S. Food and Drug Administration (FDA) on Wednesday licensed up to date COVID-19 booster pictures from Pfizer /BioNTech and Moderna that concentrate on the dominant BA.4 and BA.5 Omicron subvariants, as the federal government prepares for a fall vaccination marketing campaign that would start in just a few days. Both vaccines additionally embrace the … Read more